Verapamil in the Prophylaxis of Episodic Cluster Headache:A Double-Blind Study Versus Placebo
Neurol 54:1382-1385, Leone,M.,et al, 2000
Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids
NEJM 343:1833-1838,1886, Haller,C.A. & Benowitz,N.L., 2000
Compressive Cervical Myelopathy Due to Calcium Pyrophosphate Dihydrate Deposition Disease,Report of a Case and Review of the Literature
Arch Int Med 159:189-193, Fry,K.H.,et al, 1999
Nimodipine Treatment for Intractable Hiccups
Am J Med 106:600, Hernandez,J.L.,et al, 1999
Disorientation and Vertebral Fractures
Lancet 353:1848, McConnaughey,D.,et al, 1999
Ion Channel Diseases:Episodic Disorders of the Nervous System
Semin Neurol 19:363-369, Ptacek,L.J., 1999
Medically Induced Gingival Hyperplasia
Mayo Clin Proc 73:1196-1199, Meraw,S.J. &Sheridan,P.J., 1998
Calcium Antagonists in Patients with Aneurysmal Subarachnoid Hemorrhage
Neurol 50:876-883, Feigin,V.L.,et al, 1998
Neurological Channelopathies, Dysfunctional Ion Channels May Cause Many Neurological Diseases
BMJ 316:1104-1105, Rose,M.R., 1998
Butyrolactone-Induced Central Nervous System Depression After Ingention of RenewTrient, a"Dietary Supplement"
NEJM 339:847-848, LoVecchio,F.,et al, 1998
Ion Channels and Neurological Disease:DNA Based Diagnosis is Now Possible,and Ion Channels May be Important in Common Paroxysmal Disorders
JNNP 65:427-431, Hanna,M.G.,et al, 1998
Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997
Calcium Channels in Neurological Disease
Ann Neurol 42:275-282, Greenberg,D.A., 1997
A Boy with Heart Failure, A Thick Tongue, and Double Vision
Lancet 349:1516, Karstein,J.,et al, 1997
A News Locus for Hemiplegic Migraine Maps to Chromosome 1q31
Neurol 49:1231-1238, 11931997., Gardner,K.,et al, 1997
Stroke in Williams Syndrome
Stroke 27:143-146, Wollack,J.B.,et al, 1996
Reversible Dementia in Idiopathic Hypoparathyroidism Associated with Normocalcemia
Neurol 47:474-476, Stuerenberg,H.J.,et al, 1996
Immunoassays Fail to Detect Antibodies Against Neuronal Calcium Channels in Amyotrophic Lateral Sclerosis Serum
Ann Neurol 40:695-700, 6911996., Arsac,C.,et al, 1996
Lambert-Eaton Myasthenic Syndrome:Clinical Diagnosis,Immune-Mediated Mechanisms,and Update on Therapies
Ann Neurol 37:S63-S73, Sanders,D.B., 1995
Drugs for Migraine
The Medical Letter 37:17-20, , 1995
The Effect of Nimodipine on Essential Tremor
Neurol 45:1523-1525, Biary,N.,et al, 1995
Calcium-Channel Antibodies in the Lambert-Eaton Syndrome and Other Paraneoplastic Syndromes
NEJM 332:1467-1474, Lennon,V.A.,et al, 1995
Amyotrophic Lateral Sclerosis Patient Antibodies Label CA2+Channel a1 Subunit
Ann Neurol 35:164-171, 1311994., Fumiharu,K.,et al, 1994
Progressive Spastic Paraparesis Revealing Primary Hyperparathyroidism
Neurol 44:178-179, Thomas,P.&Lebrun,C., 1994
A Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine in Acute Ischemic Hemispheric Stroke
Stroke 25:1348-1353, Kaste,M.,et al, 1994
Prophylactic Neuroprotection for Cerebral Ischemia
Stroke 25:1075-1080, Fisher,M.,et al, 1994
Clinicopath Conf
Small Cell CA (of lung) with Lambert-Eaton Myasthenic Syndr, Case 32-1994, NEJM 331:528-5354., , 1994
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
Stroke 25:2315-2328, Mayberg,M.R.,et al, 1994
Parkinsonism Unmasked by Verapamil
Clinical Neuropharmacol 16:263-265, Garcia-Albea,E.,et al, 1993
Alternating Hemiplegia of Childhood:A Study of 10 Pts & Results of Flunarizine Treatment
Neurol 43:36-41, Silver,K.&Andermann,F., 1993
Brief Report:Treatment of Vasospastic Amaurosis Fugax with Calcium-Channel Blockers
NEJM 329:396-398, 4261993., Winterkorn,J.M.S.,et al, 1993
Alternating Hemiplegia of Childhood
J Pediatr 122:673-679, Bourgeois,M.,et al, 1993
Atenolol Compared with Nifedipine:Effect on Cognitive Function and Mood in Elderly Hypertensive Patients
Ann Int Med 116:615-623, Skinner,M.H.,et al, 1992
Cluster Headache
Neurol 42 (Suppl 2) :22-31992., Mathew,N.T., 1992
Pharmacologic Treatment of Childhood Migraine
J Pediatr 120:653-657, Ingarashi,M.,et al, 1992
Elevated Carbamazepine Levels Associated with Diltiazem Use
Neurol 42:937-938, Shaughnessy,A.F.&Mosley,M.R., 1992
Cortical Blindness after Nifedipine Treatment
BMJ 305:693, Morton,C.&Hickey-Dwyer,M., 1992
Serum Antibodies to L-Type Calcium Channels in Patients with Amyotrophic Lateral Sclerosis
NEJM 327:1721-1728, 17521992., Smith,R.G.,et al, 1992
Paraneoplastic Cerebellar Degener III, Cerebellar Degener, Cancer & Lambert-Eaton Myasthenic Synd
Neurol 42:1944-1950, Clouston,P.D.,et al, 1992
Clinical Trial of Nimodipine in Acute Ischemic Stroke
The American Nimodipine Study Group, Stroke 23:3-81992., , 1992
Subarachnoid Haemorrhage
Lancet 339:653-655, Van Gijn,J., 1992
Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome after Embolic Stroke
Arch Neurol 48:1235-1238, Zivin,J.A.&Mazzarella,V., 1991
A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Pts with AIDS
Ann Int Med 115:665-673, Palestine,A.G.,et al, 1991
A Reduction in Verapamil Concentrations with Phenytoin
NEJM 325:1179, Woodcock,B.G.,et al, 1991
Calcium Channel Autoantibodies in the Lambert-Eaton Myashenic Syndrome
Ann Neurol 29:307-314, Leys,K.,et al, 1991
A Randomized Clinical Study of a Calcium-Entry Blocker (Lidoflzaine) in the Treatment of Comatose Survivors of Cardiac Arrest
NEJM 324:1225-1231, 1278-12801991., , 1991
Recurrent Attacks of Amaurosis Fugax Treated with Calcium Channel Blocker
Ann Neurol 30:423-425, Winterkorn,J.M.S.&Teman,A.J., 1991
Early Treatment of Ischemic Stroke with a Calcium Antagonist
Stroke 22:437-441, Rosenbaum,D.,et al, 1991
Interactions Between Calcium Channel Blockers and the Anticonvulsants Carbamazepine and Phenytoin
Neurol 41:740-742, Bahls,F.H.,et al, 1991
The Effect of Flunarizine on Essential Tremor
Neurol 41:311-312, Biary,N.,et al, 1991